Literature DB >> 22247563

T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.

Yasushi Isobe1, Nanae Aritaka, Yasuhiro Setoguchi, Yoshinori Ito, Hiroshi Kimura, Yasuharu Hamano, Koichi Sugimoto, Norio Komatsu.   

Abstract

A chronic infectious mononucleosis-like illness caused by Epstein-Barr virus (EBV) is called 'chronic active EBV disease', which is defined as an EBV-associated lymphoproliferative disease. This lymphoproliferative disease is rare and predominantly occurs in Japanese children. Between 1998 and 2010, seven adult-onset cases (aged 20-45 years, median 39 years) were identified, which initially presented with inflammatory diseases, including hepatitis, interstitial pneumonitis, uveitis, nephritis and hypersensitivity to mosquito bites. They showed an EBV viral load in the peripheral blood and evidence of EBV infection of T or natural killer (NK) cells. Five cases (71.4%) developed EBV-positive T/NK-cell lymphoma/leukaemia at a median of 5 years (range 1-7 years) after the diagnosis. Although l-asparaginase-containing chemotherapy was effective for the lymphomas, only allogeneic haematopoietic cell transplantation eradicated EBV-infected cells. This observation indicates that persistent EBV infection of T or NK cells defines a distinct disease entity, which provides an underlying condition for EBV-positive T/NK-cell lymphoma/leukaemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22247563     DOI: 10.1136/jclinpath-2011-200523

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

Review 1.  How virus persistence can initiate the tumorigenesis process.

Authors:  Simone Avanzi; Gualtiero Alvisi; Alessandro Ripalti
Journal:  World J Virol       Date:  2013-05-12

Review 2.  Systemic Epstein-Barr virus-positive T/natural killer-cell lymphoproliferative disorder: a case report and review of literature.

Authors:  Xia Tan; Xianling Liu; Chunhong Hu; Fuyou Liu; Fang Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation.

Authors:  Troy A McEachron; Ivan Kirov; Minkkwan Wungwattana; Daisy Cortes; Keri B Zabokrtsky; Aaron Sassoon; David Craig; John D Carpten; Leonard S Sender
Journal:  Pediatr Blood Cancer       Date:  2016-01-05       Impact factor: 3.167

Review 4.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

5.  Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.

Authors:  Ren-Ching Wang; Sheng-Tsung Chang; Yen-Chuan Hsieh; Wan-Ting Huang; Jeng-Dong Hsu; Chih-En Tseng; Ming-Chung Wang; Wei-Shou Hwang; John Wang; Shih-Sung Chuang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

6.  Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma.

Authors:  Ki Sun Jung; Su-Hee Cho; Seok Jin Kim; Young Hyeh Ko; Won Seog Kim
Journal:  Int J Hematol       Date:  2016-07-25       Impact factor: 2.490

7.  Unusual Indolent Course of a Chronic Active Epstein-Barr Virus-Associated Natural Killer Cell Lymphoproliferative Disorder.

Authors:  Arwa Z Al-Riyami; Khalil Al-Farsi; Murtadha Al-Khabori; Mohammed Al-Huneini; Ibrahim Al-Hadabbi
Journal:  Sultan Qaboos Univ Med J       Date:  2016-05-15

Review 8.  Acute Kidney Injury Relevant to Tubulointerstitial Nephritis with Late-Onset Uveitis Superimposed by Thrombotic Microangiopathy: A Case Report and Review of the Literature.

Authors:  Youlu Zhao; Junwen Huang; Tao Su; Zhikai Yang; Xizi Zheng; Liu Yang; Xujie Zhou; Xiaojuan Yu; Hui Wang; Suxia Wang; Gang Liu; Li Yang
Journal:  Kidney Dis (Basel)       Date:  2020-05-20

9.  Unrelated cord blood transplantation for adult-onset EBV-associated T-cell and NK-cell lymphoproliferative disorders.

Authors:  Yasushi Onishi; Koichi Onodera; Noriko Fukuhara; Hiroki Kato; Satoshi Ichikawa; Tohru Fujiwara; Hisayuki Yokoyama; Minami Yamada-Fujiwara; Hideo Harigae
Journal:  Int J Hematol       Date:  2022-03-10       Impact factor: 2.490

10.  EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood.

Authors:  Mineui Hong; Young Hyeh Ko; Keon Hee Yoo; Hong Hoe Koo; Seok Jin Kim; Won Seog Kim; Heejung Park
Journal:  Korean J Pathol       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.